28th Feb 2005 13:06
Futura Medical PLC28 February 2005 RNS Release 28 February 2005 Futura Medical change in Nominated Adviser and Broker Futura Medical plc ("Futura"), the AIM-quoted pharmaceutical drug and medicaldevice group that develops innovative products for the sexual healthcare market,announces the following adviser appointments with immediate effect: Nominated AdviserCanaccord Capital (Europe) Limited Joint brokersCollins Stewart Limited Canaccord Capital (Europe) Limited remains joint broker. For further information:Futura Medical plcJames Barder, Chief Executive Tel: +44 (0) 1483 845 670 Canaccord Capital (Europe) LtdStephen Rowntree Tel: +44 (0)20 7518 7371 Collins Stewart LtdChris Howard Tel: + 44 (0) 20 7523 8350 Media enquiries:AbchurchPeter Curtain / Alex Tweed Tel: +44 (0) 20 7398 7700mailto: [email protected] www.abchurch-group.com www.futuramedical.co.uk This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Futura Medical